Schedule 13G ownership disclosure

XERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98422L107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,647,218
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000834237-21-005690
Form type
SC 13G/A
Filer
BlackRock Finance, Inc.
CIK
CIK 1364742
Filed
Feb 01, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub